|
시장보고서
상품코드
1463021
임상시험 이미징 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제공별, 양식별, 용도별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032 |
||||||
Polaris Market Research의 최신 연구에 따르면, 세계 임상시험 이미징 시장 규모는 2032년까지 22억 5,012만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
임상시험 이미징 시장은 전 세계적으로 만성질환의 확산에 힘입어 성장하고 있습니다. 심혈관 질환, 암, 신경 질환 등의 질병이 증가함에 따라 치료법 개발에 대한 노력이 증가하고 있으며, MRI, CT, PET, 초음파 등의 임상시험 이미징은 질병의 진행, 치료 반응 및 환자 결과를 평가하는 데 있어 매우 중요한 역할을 하고 있습니다. 새로운 치료법을 평가하기 위해 더 크고 복잡한 임상시험이 진행되는 가운데, 영상 평가 항목은 치료 효과의 객관적인 지표가 될 수 있습니다. 규제 당국은 의약품 승인을 위해 강력한 영상 데이터를 요구하고 있으며, 이는 임상시험 이미징 서비스에 대한 수요를 더욱 증가시키고 있습니다.
임상시험 이미징 시장은 이미징 바이오마커의 사용 확대도 성장의 원동력이 되고 있습니다. 이러한 바이오마커는 생물학적 과정과 치료 반응에 대한 정량적 측정을 제공하여 다양한 치료 영역에서 질병 모니터링과 치료 평가에 도움을 줍니다. 정밀의료와 맞춤치료에서 중요한 역할을 수행하여 표적화된 개입을 가능하게 하고 치료 결과를 개선합니다. 이미징 기술과 분석 방법의 발전으로 임상에서 사용할 수 있는 이미징 바이오마커의 폭이 넓어지고 있습니다. 또한 인공지능(AI)과 기계학습 알고리즘의 통합은 바이오마커 분석을 강화하고 데이터 처리를 간소화하며 임상시험의 재현성을 향상시키고 있습니다.
인공지능(AI) 기술의 통합은 임상시험 이미징 시장에 큰 기회를 가져다 줄 것입니다. 머신러닝 및 딥러닝 모델과 같은 AI 알고리즘은 작업 자동화, 오류 감소, 데이터 처리 속도 향상으로 의료 영상 분석에 혁명을 일으킬 수 있습니다. 임상시험에서 AI 기반 이미지 분석은 이미지 바이오마커의 미묘한 변화를 신속하게 식별하여 효율성을 높이고, 치료 반응을 조기에 발견할 수 있도록 돕습니다. 또한, AI 기반 솔루션은 대규모 영상 데이터 세트에서 귀중한 인사이트를 도출하여 환자 계층화 및 치료 선택에 도움을 줍니다. 확장성과 적응성을 통해 임상시험 운영을 간소화하고 이해관계자 간의 협업을 촉진합니다.
MRI, PET, CT, 광학 이미징과 같은 서로 다른 영상 양식을 결합하여 연구자들은 보완적인 정보를 얻을 수 있어 진단의 정확성과 치료 평가를 향상시킬 수 있습니다. 멀티모달 이미징은 개별 영상기법의 한계를 극복하고 질병 병태생리와 치료 효과에 대한 종합적인 이해를 제공합니다. 또한 여러 영상 매개변수를 결합하여 새로운 영상 바이오마커를 쉽게 개발할 수 있어 질병 진행과 치료 효과에 대한 인사이트를 높일 수 있습니다. 또한, 이미지 등록, 융합 기술 및 AI 알고리즘의 발전은 데이터 분석의 효율성을 높이고 임상시험 설계 및 수행의 혁신을 촉진할 수 있습니다.
임상시험 이미징 시장 보고서 하이라이트
2023년에는 전체 임상시험 과정에서 필수적인 역할, 유연성과 확장성, 비용 효율성으로 인해 운영 이미징 서비스 부문이 상당한 매출 점유율을 차지했습니다.
2023년 컴퓨터 단층 촬영 분야는 진단의 다양성, 광범위한 응용 범위, 빠른 이미지 획득으로 인해 큰 수익 점유율을 차지했습니다.
2023년 종양학 부문은 종양학 임상시험의 높은 발생률, 종양학 임상시험의 복잡성, 종양학 의약품 파이프라인의 증가로 인해 큰 수익 점유율을 차지했습니다.
제약 및 생명공학 기업의 수요는 의약품 개발 이니셔티브, 정밀 의료의 발전, 치료 혁신으로 인해 예측 기간 동안 증가할 것으로 예상됩니다.
2023년에는 북미가 높은 수준의 의료 인프라, 많은 임상시험, 대형 제약사의 존재로 인해 큰 시장 점유율을 차지했습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 임상시험 이미징 시장 인사이트
- 임상시험 이미징 - 업계 현황
- 임상시험 이미징 시장 역학
- 성장 촉진요인과 기회
- 임상시험 활동 증가에 의해 제품 수요가 촉진될 것으로 예측됩니다.
- 영상 기술 진보에 의해 임상시험 이미징 시장의 성장이 촉진될 것으로 기대됩니다.
- 성장 억제요인과 과제
- 영상 진단 서비스의 고비용은 시장 성장을 저해할 가능성이 높습니다.
- 성장 촉진요인과 기회
- PESTLE 분석
- 임상시험 이미징 업계 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 제공별 세계 시장
- 주요 조사 결과
- 소개
- 임상시험 설계와 컨설팅 서비스
- 운영 이미징 서비스
- 프로젝트와 데이터 관리
- 리딩 및 분석 서비스
- 시스템 및 테크놀러지 서포트 서비스
- 기타
제6장 모달리티별 세계 시장
- 주요 조사 결과
- 소개
- 초음파
- 컴퓨터 단층촬영
- X선
- 자기공명영상
- 기타
제7장 용도별 세계 시장
- 주요 조사 결과
- 소개
- 신경학
- 종양학
- 감염증
- 내분비학
- 안과
- 심혈관질환
- 기타
제8장 최종사용자별 세계 시장
- 주요 조사 결과
- 소개
- 제약·바이오테크놀러지 기업
- 계약 조사기관
- 의료기기 제조업체
- 학술기관 및 정부 조사기관
- 기타
제9장 지역별 세계 시장
- 주요 조사 결과
- 소개
- 임상시험 이미징 시장 평가, 지역별, 2019-2032년
- 임상시험 이미징 시장 - 북미
- 북미 : 임상시험 이미징 시장, 제공별, 2019-2032년
- 북미 : 임상시험 이미징 시장, 최종사용자별, 2019-2032년
- 북미 : 임상시험 이미징 시장, 모달리티별, 2019-2032년
- 북미 : 임상시험 이미징 시장, 용도별, 2019-2032년
- 임상시험 이미징 시장 - 미국
- 임상시험 이미징 시장 - 캐나다
- 임상시험 이미징 시장 - 유럽
- 유럽 : 임상시험 이미징 시장, 제공별, 2019-2032년
- 유럽 : 임상시험 이미징 시장, 최종사용자별, 2019-2032년
- 유럽 : 임상시험 이미징 시장, 모달리티별, 2019-2032년
- 유럽 : 임상시험 이미징 시장, 용도별, 2019-2032년
- 임상시험 이미징 시장 - 영국
- 임상시험 이미징 시장 - 프랑스
- 임상시험 이미징 시장 - 독일
- 임상시험 이미징 시장 - 이탈리아
- 임상시험 이미징 시장 - 스페인
- 임상시험 이미징 시장 - 네델란드
- 임상시험 이미징 시장 - 러시아
- 임상시험 이미징 시장 - 아시아태평양
- 아시아태평양 : 임상시험 이미징 시장, 제공별, 2019-2032년
- 아시아태평양 : 임상시험 이미징 시장, 최종사용자별, 2019-2032년
- 아시아태평양 : 임상시험 이미징 시장, 모달리티별, 2019-2032년
- 아시아태평양 : 임상시험 이미징 시장, 용도별, 2019-2032년
- 임상시험 이미징 시장 - 중국
- 임상시험 이미징 시장 - 인도
- 임상시험 이미징 시장 - 일본
- 임상시험 이미징 시장 - 말레이시아
- 임상시험 이미징 시장 - 인도네시아
- 임상시험 이미징 시장 - 한국
- 임상시험 이미징 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 임상시험 이미징 시장, 제공별, 2019-2032년
- 중동 및 아프리카 : 임상시험 이미징 시장, 최종사용자별, 2019-2032년
- 중동 및 아프리카 : 임상시험 이미징 시장, 모달리티별, 2019-2032년
- 중동 및 아프리카 : 임상시험 이미징 시장, 용도별, 2019-2032년
- 임상시험 이미징 시장 - 사우디아라비아
- 임상시험 이미징 시장 - 남아프리카
- 임상시험 이미징 시장 - 이스라엘
- 임상시험 이미징 시장 - UAE
- 임상시험 이미징 시장 - 라틴아메리카
- 라틴아메리카 : 임상시험 이미징 시장, 제공별, 2019-2032년
- 라틴아메리카 : 임상시험 이미징 시장, 최종사용자별, 2019-2032년
- 라틴아메리카 : 임상시험 이미징 시장, 모달리티별, 2019-2032년
- 라틴아메리카 : 임상시험 이미징 시장, 용도별, 2019-2032년
- 임상시험 이미징 시장 - 멕시코
- 임상시험 이미징 시장 - 브라질
- 임상시험 이미징 시장 - 아르헨티나
제10장 경쟁 상황
- 확대와 인수 분석
- 확대
- 인수
- 파트너십/협업/계약/공개
제11장 기업 개요
- BioClinica
- Biomedical Systems Corp
- BioTelemetry, Inc.
- Cardiovascular Imaging Technologies
- ICON plc
- Intrinsic Imaging
- IXICO plc
- Median Technologies
- Medpace
- Merge Healthcare
- Navitas Clinical Research, Inc
- ProScan Imaging
- Radiant Sage LLC
- Resonance Health
- WorldCare Clinical
The global clinical trial imaging market size is expected to reach USD 2,250.12 Million by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The clinical trial imaging market is propelled by the escalating prevalence of chronic diseases globally. Conditions like cardiovascular diseases, cancer, and neurological disorders are increasing, prompting heightened efforts in therapy development. Clinical trial imaging, utilizing modalities such as MRI, CT, PET, and ultrasound, plays a pivotal role in evaluating disease progression, treatment response, and patient outcomes. With larger and more intricate trials conducted to assess new interventions, imaging endpoints provide objective measures of treatment effects. Regulatory agencies mandate robust imaging data for drug approval, further boosting the demand for clinical trial imaging services.
The clinical trial imaging market is also experiencing growth driven by the expanding applications of imaging biomarkers. These biomarkers offer quantitative measurements of biological processes or treatment responses, aiding in disease monitoring and treatment evaluation across various therapeutic areas. They play a crucial role in precision medicine and personalized therapies, enabling targeted interventions and improving therapeutic outcomes. Advancements in imaging technologies and analytical methods have broadened the range of imaging biomarkers available for clinical use. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced biomarker analysis, streamlining data processing and improving reproducibility in clinical trials.
The integration of artificial intelligence (AI) technologies presents significant opportunities in the clinical trial imaging market. AI algorithms, such as machine learning and deep learning models, revolutionize medical image analysis by automating tasks, reducing errors, and expediting data processing. In clinical trials, AI-driven imaging analysis enhances efficiency by rapidly identifying subtle changes in imaging biomarkers, facilitating early treatment response detection. Moreover, AI-based solutions unlock valuable insights from large-scale imaging datasets, aiding in patient stratification and treatment selection. Their scalability and adaptability streamline trial operations, fostering collaboration among stakeholders.
By combining different imaging modalities like MRI, PET, CT, and optical imaging, researchers obtain complementary information, improving diagnostic accuracy and treatment assessment. Multi-modal imaging offers a comprehensive understanding of disease pathology and treatment effects, overcoming the limitations of individual modalities. It facilitates the development of novel imaging biomarkers by combining multiple imaging parameters, enhancing insights into disease progression and treatment response. Furthermore, advancements in image registration, fusion techniques, and AI algorithms streamline data analysis, driving innovation in clinical trial design and execution.
Clinical Trial Imaging Market Report Highlights
In 2023, the operational imaging services segment held considerable revenue share owing to its essential role in entire clinical trial process, flexibility and scalability, and cost-effectiveness.
In 2023, the computed tomography segment held significant revenue share owing to diagnostic versatility, wide application spectrum, and rapid imaging acquisition.
In 2023, the oncology segment held significant revenue share owing to high incidence of oncology trials, complexity of oncology trials, and growing pipeline of oncology drugs.
The demand from pharmaceutical & biotechnology companies is expected to increase during the forecast period owing to drug development initiatives, precision medicine advancements, and therapeutic innovation.
In 2023, North America region accounted for a significant market share due to advanced healthcare infrastructure, high volume of clinical trials, and presence of leading pharmaceutical companies.
The market is highly competitive owing to the existence of market players with a global presence, including BioClinica, BioTelemetry, Inc., Cardiovascular Imaging Technologies, ICON plc, Merge Healthcare, Navitas Clinical Research, Inc, Resonance Health, and WorldCare Clinical among others.
Polaris Market Research has segmented the Clinical Trial Imaging market report based on offering, modality, application, end user, and region:
Clinical Trial Imaging, Offering Outlook (Revenue - USD Million, 2019 - 2032)
- Clinical Trial Design and Consultation Services
- Operational Imaging Services
- Project and Data Management
- Reading and Analytical Services
- System and Technology Support Services
- Others
Clinical Trial Imaging, Modality Outlook (Revenue - USD Million, 2019 - 2032)
- Ultrasound
- Computed Tomography
- X-Ray
- Magnetic Resonance Imaging
- Others
Clinical Trial Imaging, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Neurology
- Oncology
- Infectious Diseases
- Endocrinology
- Ophthalmology
- Cardiovascular Diseases
- Others
Clinical Trial Imaging, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Medical Device Manufacturers
- Academic and Government Research Institutes
- Others
Clinical Trial Imaging, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Clinical Trial Imaging Market Insights
- 4.1. Clinical Trial Imaging - Industry Snapshot
- 4.2. Clinical Trial Imaging Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing clinical trial activities are projected to spur the product demand
- 4.2.1.2. Advancement in imaging technologies is expected to drive clinical trial imaging market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of imaging services is likely to impede the market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Clinical Trial Imaging Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Clinical Trial Imaging Market, by Offering
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 5.3. Clinical Trial Design and Consultation Services
- 5.3.1. Global Clinical Trial Imaging Market, by Clinical Trial Design and Consultation Services, by Region, 2019-2032 (USD Million)
- 5.4. Operational Imaging Services
- 5.4.1. Global Clinical Trial Imaging Market, by Operational Imaging Services, by Region, 2019-2032 (USD Million)
- 5.5. Project and Data Management
- 5.5.1. Global Clinical Trial Imaging Market, by Project and Data Management, by Region, 2019-2032 (USD Million)
- 5.6. Reading and Analytical Services
- 5.6.1. Global Clinical Trial Imaging Market, by Reading and Analytical Services, by Region, 2019-2032 (USD Million)
- 5.7. System and Technology Support Services
- 5.7.1. Global Clinical Trial Imaging Market, by System and Technology Support Services, by Region, 2019-2032 (USD Million)
- 5.8. Others
- 5.8.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Clinical Trial Imaging Market, by Modality
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 6.3. Ultrasound
- 6.3.1. Global Clinical Trial Imaging Market, by Ultrasound, by Region, 2019-2032 (USD Million)
- 6.4. Computed Tomography
- 6.4.1. Global Clinical Trial Imaging Market, by Computed Tomography, by Region, 2019-2032 (USD Million)
- 6.5. X-Ray
- 6.5.1. Global Clinical Trial Imaging Market, by X-Ray, by Region, 2019-2032 (USD Million)
- 6.6. Magnetic Resonance Imaging
- 6.6.1. Global Clinical Trial Imaging Market, by Magnetic Resonance Imaging, by Region, 2019-2032 (USD Million)
- 6.7. Others
- 6.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Clinical Trial Imaging Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 7.3. Neurology
- 7.3.1. Global Clinical Trial Imaging Market, by Neurology, by Region, 2019-2032 (USD Million)
- 7.4. Oncology
- 7.4.1. Global Clinical Trial Imaging Market, by Oncology, by Region, 2019-2032 (USD Million)
- 7.5. Infectious Diseases
- 7.5.1. Global Clinical Trial Imaging Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
- 7.6. Endocrinology
- 7.6.1. Global Clinical Trial Imaging Market, by Endocrinology, by Region, 2019-2032 (USD Million)
- 7.7. Ophthalmology
- 7.7.1. Global Clinical Trial Imaging Market, by Ophthalmology, by Region, 2019-2032 (USD Million)
- 7.8. Cardiovascular Diseases
- 7.8.1. Global Clinical Trial Imaging Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Million)
- 7.9. Others
- 7.9.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)
8. Global Clinical Trial Imaging Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global Clinical Trial Imaging Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
- 8.4. Contract Research Organizations
- 8.4.1. Global Clinical Trial Imaging Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
- 8.5. Medical Device Manufacturers
- 8.5.1. Global Clinical Trial Imaging Market, by Medical Device Manufacturers, by Region, 2019-2032 (USD Million)
- 8.6. Academic and Government Research Institutes
- 8.6.1. Global Clinical Trial Imaging Market, by Academic and Government Research Institutes, by Region, 2019-2032 (USD Million)
- 8.7. Others
- 8.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)
9. Global Clinical Trial Imaging Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Clinical Trial Imaging Market Assessment, By Geography, 2019-2032 (USD Million)
- 9.3. Clinical Trial Imaging Market - North America
- 9.3.1. North America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.3.2. North America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.3.3. North America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.3.4. North America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.3.5. Clinical Trial Imaging Market - U.S.
- 9.3.5.1. U.S.: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.3.5.2. U.S.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.3.5.3. U.S.: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.3.5.4. U.S.: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.3.6. Clinical Trial Imaging Market - Canada
- 9.3.6.1. Canada: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.3.6.2. Canada: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.3.6.3. Canada: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.3.6.4. Canada: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4. Clinical Trial Imaging Market - Europe
- 9.4.1. Europe: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.2. Europe: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.3. Europe: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.4. Europe: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.5. Clinical Trial Imaging Market - UK
- 9.4.5.1. UK: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.5.2. UK: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.5.3. UK: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.5.4. UK: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.6. Clinical Trial Imaging Market - France
- 9.4.6.1. France: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.6.2. France: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.6.3. France: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.6.4. France: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.7. Clinical Trial Imaging Market - Germany
- 9.4.7.1. Germany: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.7.2. Germany: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.7.3. Germany: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.7.4. Germany: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.8. Clinical Trial Imaging Market - Italy
- 9.4.8.1. Italy: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.8.2. Italy: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.8.3. Italy: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.8.4. Italy: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.9. Clinical Trial Imaging Market - Spain
- 9.4.9.1. Spain: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.9.2. Spain: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.9.3. Spain: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.9.4. Spain: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.10. Clinical Trial Imaging Market - Netherlands
- 9.4.10.1. Netherlands: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.10.2. Netherlands: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.10.3. Netherlands: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.10.4. Netherlands: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.4.11. Clinical Trial Imaging Market - Russia
- 9.4.11.1. Russia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.4.11.2. Russia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.4.11.3. Russia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.4.11.4. Russia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5. Clinical Trial Imaging Market - Asia Pacific
- 9.5.1. Asia Pacific: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.5. Clinical Trial Imaging Market - China
- 9.5.5.1. China: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.5.2. China.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.5.3. China: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.5.4. China: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.6. Clinical Trial Imaging Market - India
- 9.5.6.1. India: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.6.2. India.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.6.3. India: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.6.4. India: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.7. Clinical Trial Imaging Market - Japan
- 9.5.7.1. Japan: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.7.2. Japan.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.7.3. Japan: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.7.4. Japan: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.8. Clinical Trial Imaging Market - Malaysia
- 9.5.8.1. Malaysia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.8.2. Malaysia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.8.3. Malaysia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.8.4. Malaysia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.9. Clinical Trial Imaging Market - Indonesia
- 9.5.9.1. Indonesia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.9.2. Indonesia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.9.3. Indonesia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.9.4. Indonesia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.5.10. Clinical Trial Imaging Market - South Korea
- 9.5.10.1. South Korea: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.5.10.2. South Korea.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.5.10.3. South Korea: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.5.10.4. South Korea: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.6. Clinical Trial Imaging Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.6.5. Clinical Trial Imaging Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.6.5.2. Saudi Arabia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.6.5.3. Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.6.5.4. Saudi Arabia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.6.6. Clinical Trial Imaging Market - South Africa
- 9.6.6.1. South Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.6.6.2. South Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.6.6.3. South Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.6.6.4. South Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.6.7. Clinical Trial Imaging Market - Israel
- 9.6.7.1. Israel: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.6.7.2. Israel: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.6.7.3. Israel: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.6.7.4. Israel: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.6.8. Clinical Trial Imaging Market - UAE
- 9.6.8.1. UAE: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.6.8.2. UAE: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.6.8.3. UAE: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.6.8.4. UAE: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.7. Clinical Trial Imaging Market - Latin America
- 9.7.1. Latin America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.7.2. Latin America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.7.3. Latin America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.7.4. Latin America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.7.5. Clinical Trial Imaging Market - Mexico
- 9.7.5.1. Mexico: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.7.5.2. Mexico: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.7.5.3. Mexico: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.7.5.4. Mexico: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.7.6. Clinical Trial Imaging Market - Brazil
- 9.7.6.1. Brazil: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.7.6.2. Brazil: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.7.6.3. Brazil: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.7.6.4. Brazil: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
- 9.7.7. Clinical Trial Imaging Market - Argentina
- 9.7.7.1. Argentina: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
- 9.7.7.2. Argentina: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
- 9.7.7.3. Argentina: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
- 9.7.7.4. Argentina: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. BioClinica
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Biomedical Systems Corp
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. BioTelemetry, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Cardiovascular Imaging Technologies
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. ICON plc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Intrinsic Imaging
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. IXICO plc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Median Technologies
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Medpace
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Merge Healthcare
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Navitas Clinical Research, Inc
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. ProScan Imaging
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Radiant Sage LLC
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Resonance Health
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. WorldCare Clinical
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
